Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 13085

1.

Drugged driving: increased traffic risks involving licit and illicit substances.

Pilkinton MW, Robertson A, McCluskey DL.

J Drug Educ. 2013;43(2):183-201.

PMID:
25068170
[PubMed - in process]
2.

Experiences of Australian school staff in addressing student cannabis use.

Gates PJ, Norberg MM, Dillon P, Manocha R.

J Drug Educ. 2013;43(2):121-39.

PMID:
25068166
[PubMed - in process]
3.

One-pot heterogeneous synthesis of Δ3-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB1 and CB2 receptors.

Rosati O, Messina F, Pelosi A, Curini M, Petrucci V, Gertsch J, Chicca A.

Eur J Med Chem. 2014 Jul 19;85C:77-86. doi: 10.1016/j.ejmech.2014.07.062. [Epub ahead of print]

PMID:
25072877
[PubMed - as supplied by publisher]
4.

Factors Affecting Noncompliance With Buprenorphine Maintenance Treatment.

Fareed A, Eilender P, Ketchen B, Buchanan-Cummings AM, Scheinberg K, Crampton K, Nash A, Shongo-Hiango H, Drexler K.

J Addict Med. 2014 Jul 28. [Epub ahead of print]

PMID:
25072677
[PubMed - as supplied by publisher]
5.

Patterns of tobacco smoking among illicit drug users in Australia 2001-2010.

Fraser D, Gartner C, Hall W.

Drug Alcohol Rev. 2014 Jul 29. doi: 10.1111/dar.12187. [Epub ahead of print]

PMID:
25069871
[PubMed - as supplied by publisher]
6.

Cannabis potency in the Venice area (Italy): Update 2013.

Zamengo L, Frison G, Bettin C, Sciarrone R.

Drug Test Anal. 2014 Jul 28. doi: 10.1002/dta.1690. [Epub ahead of print]

PMID:
25069834
[PubMed - as supplied by publisher]
7.

Letter to the Editor: Cannabis use and transition to psychosis: is interpretation of unpleasant effects a mediating variable?

Richardson T, Hughes M, Leech K, Raman S.

Psychol Med. 2014 Jun 20:1. [Epub ahead of print] No abstract available.

PMID:
25066783
[PubMed - as supplied by publisher]
8.

Natural course of cannabis use disorders.

Farmer RF, Kosty DB, Seeley JR, Duncan SC, Lynskey MT, Rohde P, Klein DN, Lewinsohn PM.

Psychol Med. 2014 May 12:1-10. [Epub ahead of print]

PMID:
25066537
[PubMed - as supplied by publisher]
9.

Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children.

Gage SH, Hickman M, Heron J, Munafò MR, Lewis G, Macleod J, Zammit S.

Psychol Med. 2014 Apr 10:1-10. [Epub ahead of print]

PMID:
25066001
[PubMed - as supplied by publisher]
10.

Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control.

Bhattacharyya S, Iyegbe C, Atakan Z, Martin-Santos R, Crippa JA, Xu X, Williams S, Brammer M, Rubia K, Prata D, Collier DA, McGuire PK.

Psychol Med. 2014 Apr 29:1-14. [Epub ahead of print]

PMID:
25065544
[PubMed - as supplied by publisher]
11.

A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial.

Barrowclough C, Marshall M, Gregg L, Fitzsimmons M, Tomenson B, Warburton J, Lobban F.

Psychol Med. 2014 Mar 5:1-13. [Epub ahead of print]

PMID:
25065535
[PubMed - as supplied by publisher]
12.

How much do we know about schizophrenia and how well do we know it? Evidence from the Schizophrenia Library.

Matheson SL, Shepherd AM, Carr VJ.

Psychol Med. 2014 Feb 20:1-19. [Epub ahead of print]

PMID:
25065407
[PubMed - as supplied by publisher]
13.

Drug Use, Abuse, and Dependence and the Persistence of Nicotine Dependence.

Goodwin RD, Sheffer CE, Chartrand H, Bhaskaran J, Hart CL, Sareen J, Bolton J.

Nicotine Tob Res. 2014 Jul 25. pii: ntu115. [Epub ahead of print]

PMID:
25063773
[PubMed - as supplied by publisher]
14.

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.

Oláh A, Tóth BI, Borbíró I, Sugawara K, Szöllõsi AG, Czifra G, Pál B, Ambrus L, Kloepper J, Camera E, Ludovici M, Picardo M, Voets T, Zouboulis CC, Paus R, Bíró T.

J Clin Invest. 2014 Jul 25. pii: 64628. doi: 10.1172/JCI64628. [Epub ahead of print]

PMID:
25061872
[PubMed - as supplied by publisher]
15.

High Frequency of Intracranial Arterial Stenosis and Cannabis Use in Ischaemic Stroke in the Young.

Wolff V, Armspach JP, Beaujeux R, Manisor M, Rouyer O, Lauer V, Meyer N, Marescaux C, Geny B.

Cerebrovasc Dis. 2014 Jul 23;37(6):438-443. [Epub ahead of print]

PMID:
25059999
[PubMed - as supplied by publisher]
16.

Detecting Cannabis Use on the Human Skin Surface via an Electronic Nose System.

Voss A, Witt K, Kaschowitz T, Poitz W, Ebert A, Roser P, Bär KJ.

Sensors (Basel). 2014 Jul 23;14(7):13256-72. doi: 10.3390/s140713256.

PMID:
25057136
[PubMed - in process]
Free Article
17.

Prognosis of schizophrenia in persons with and without a history of cannabis use.

Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P.

Psychol Med. 2014 Sep;44(12):2513-21. doi: 10.1017/S0033291714000191.

PMID:
25055170
[PubMed - in process]
Free PMC Article
18.

Cannabis use and transition to psychosis in people at ultra-high risk.

Valmaggia LR, Day FL, Jones C, Bissoli S, Pugh C, Hall D, Bhattacharyya S, Howes O, Stone J, Fusar-Poli P, Byrne M, McGuire PK.

Psychol Med. 2014 Sep;44(12):2503-12. doi: 10.1017/S0033291714000117.

PMID:
25055169
[PubMed - in process]
19.

Identification of potential herbal inhibitor of acetylcholinesterase associated Alzheimer's disorders using molecular docking and molecular dynamics simulation.

Seniya C, Khan GJ, Uchadia K.

Biochem Res Int. 2014;2014:705451. doi: 10.1155/2014/705451. Epub 2014 May 14.

PMID:
25054066
[PubMed]
Free PMC Article
20.

Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary investigation.

Earleywine M, Bolles JR.

J Psychoactive Drugs. 2014 Jul-Aug;46(3):171-7. doi: 10.1080/02791072.2014.920118.

PMID:
25052875
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk